migores1

TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

VaselineAugust 17, 2024

0 1 minute read

TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

TNXP Stock - TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

Source: iQoncept / Shutterstock

Tonix Pharmaceuticals (NASDAQ:TNXP) just reported results for the second quarter of 2024.

Tonix Pharmaceuticals reported -$19.28 earnings per share. This was below the analyst estimate for EPS of -$7.20.
The company reported revenue of $2.21 million.
This was 34.09% worse than analysts’ estimate for revenue of $3.35 million.

InvestorPlace Earnings is a project that uses data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways, including earnings per share and revenue, as well as how a company measures up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers about the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected].

Print article from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/tnxp-stock-earnings-tonix-pharmaceuticals-for-q2-of-2024/.

VaselineAugust 17, 2024

0 1 minute read

Vaseline

Related Articles

AMD Looks Poised for Breakout or Breakdown (Technical Analysis)

The release of EigenLayer tokens draws a check on supply concerns

North Korea is opening up to international tourists (yes, really)

TON Leads the Flat Crypto Market as HashKey Announces Catizen Partnership